Details For Selected Brain Tumor Treatment
Sponsored By
Please Click On The Above Banner For More Details
Braintumor Website

Back to New Treatments List Back to New Treatments List

Treatment Name: Bevacizumab (Avastin) and Irinotecan (CPT-11) in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
Phase: Phase 2
Treatment ID#: 1893        
Age Group: Pediatric Only
Min Karnofsky Score: Not Specified
Conditions: Prior Surgery is Allowed
Prior Radiation is Allowed
Prior Chemotherapy is Allowed
Last Updated: 11/08/2008
Tumor Types: Anaplastic Astrocytoma
Brainstem Glioma
Ependyoma
Glioblastoma Multiforme
Low Grade Glioma
Medulloblastoma
Mixed Glioma
Oligodendroglioma High Grade
Comments:
Treatment Type: Chemotherapy
Less-Toxics
Contact: Clinical Trials Office - Warren Grant Magnusen Clinical Center



Bethesda, MD 20892 USA
Phone: 888-NCI-1937
Fax:
E-mail:
Website:
  • Last updated refers to the date when our listing for each treatment was last updated.
  • ID is a combination of our internal ID and the official ID for the trial, if any.
  • Min Karnofsky is a general guide to how well you have to function to use this treatment


Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Chat | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book

IF YOU ARE USING A SCREEN READER, CLICK HERE
[Click HERE to open a Printer Friendly Version Of This Page!]

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By
World Wide Websites